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Germinal centres are anatomically defined lymphoid organ structures that mediate B 
cell affinity maturation and affect the quality of humoral immune responses. 
Mathematical models based on differential equations or agent-based simulations have 
been widely used to deepen our understanding of the cellular and molecular processes 
characterizing these complex dynamic systems. Along with experimental studies, these 
tools have provided insights into the spatio-temporal behavior of B cells in germinal 
center reactions and the mechanisms underlying their clonal selection and cellular 
differentiation. More recently, mathematical models have been used to define key 
parameters that influence the quality of humoral vaccine responses such as vaccine 
composition and vaccination schedule. These studies generated testable predictions 
for the design of optimized immunization strategies. 
 
 
Graphical Abstract - Basic structure and applications of germinal centre simulations. 
 
Introduction 
 
B cells are components of the adaptive immune system of higher vertebrates. Their main 
function is the production of soluble serum antibodies for neutralising pathogens. Each naïve 
B cell expresses a unique B cell antigen receptor (BCR), the membrane-bound form of its 
antibody, because the corresponding immunoglobulin (Ig) gene region is shaped by random 
genetic recombination during cellular development. This process alone yields a potential 
diversity of 1018 different BCR sequences in humans, largely exceeding the number of B cells 
in the body [1]. The diversity of the resulting B cell repertoire is mostly confined to the 
complementarity-determining regions (CDRs) of the antibodies, areas specialized for 
contacting and binding antigen, while the less diverse framework regions (FWRs) convey 
protein shape and stability. 
 
Following infection or vaccination, those B cells whose BCRs bind to the foreign epitopes with 
above-threshold affinity are activated and recruited into the immune response. In the case of 
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T cell-dependent antigens, activated B cells migrate to secondary lymphoid follicles where they 
seed germinal centres (GCs) [2–5]. In addition to proliferating B cells, these anatomically 
defined structures contain follicular dendritic cells (FDCs), stromal cells and T follicular helper 
(Tfh) cells. All three cell populations are essential mediators of affinity maturation, that is the 
improvement of humoral immunity with time and antigen exposure through the competitive 
selection of B cells with highest antigen affinity [6]. Serum antibodies influence ongoing GC 
reactions by antibody feedback, as stromal cells display antigen in the form of antibody-
containing immune complexes and serum antibodies bind to FDC-displayed antigen in 
competition with GC B cells. Of note, GCs are unable to select for pathogen neutralisation, as 
antigenic epitopes are presented out of their functional context. GC selection is thus based on 
antibody-antigen affinity alone. 
 
Within GCs, B cells actively mutate their immunoglobulin genes. This random somatic 
hypermutation process has the potential to generate B cell antigen receptors with improved 
affinity to their cognate antigen [7]. Ultimately, GC reactions improve humoral immune 
responses through the differentiation of GC B cells into short- and long-lived antibody-secreting 
plasma cells and the formation of memory B cells which can quickly respond to antigenic re-
challenge [8,9].  
 
Soon after the definitive experimental establishment of GCs as the sites of somatic 
hypermutation and affinity maturation based on rodent studies with model antigen [10,11], first 
mathematical models of the GC reaction were developed [12,13] as “data-interpretation tools” 
and to raise novel hypotheses [14]. Since then, experimental advances, particularly due to the 
use of novel in vivo imaging technologies [12,13], and model-based interpretation and 
formation of questions succeed each other in cycles; examples in which in silico exploration 
has preceded definite experimental validation include cycling of GC B cells between zones of 
mutation and selection [12,15], the existence of serum-antibody feedback in GCs [16,17] and 
the role of Tfh cells in GC selection [18,19].  
 
In recent years, following breakthroughs in high-throughput single-cell Ig gene sequencing and 
expression cloning, large datasets have become available that allow monitoring B cell clonal 
diversification and expansion linked to BCR affinity [20–26]. This integrative approach opened 
a window to assess affinity maturation against real-world pathogens in humans during natural 
infection and in response to vaccination. In parallel, increasing numbers of vaccination-focused 
GC simulation studies have emerged. These integrate the available body of mostly mouse-
derived knowledge and extrapolate to the human setting [27–30]. Such models aim at 
improving vaccine design in terms of vaccine composition and administration schedules. 
 
Here, we review the most recent mathematical and computational models of the GC response, 
highlight interesting model features and discuss how they helped to improve our understanding 
of B cell responses specifically in vaccination settings. An overview of studies published since 
2016 is given in Table 1 including information on the availability of the simulation codes. With 
this, we hope to facilitate the re-use and improvement of existing simulations as well as the 
development of new ones to address key questions in basic and applied immunology hand-in-
hand with experimental data.  
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Constructing theoretical GC models 
 
Computational models of the GC reaction commonly take the form of agent-based stochastic 
simulations [31], systems of ordinary differential equations or combinations thereof. 
Alternatively, stochastic differential equations are employed. Independent of the framework 
used, core processes of the GC reaction must be cast into equations and computer-executable 
rules. As sketched in Figure 1, these include descriptions of cellular division, somatic 
hypermutation, competition and selection. Most models also formalize GC cell entry or seeding 
and GC exit via differentiation. Since affinity maturation via selection and mutation is intimately 
linked to the binding energy or affinity between antigen and antibodies, a set of rules yielding 
affinities between computational antigen and antibodies is required. Binding models are often 
designed with a specific research question in mind and have recently been reviewed in depth 
elsewhere [32]. 
 
Each of the core processes – activation, mutation, selection and differentiation – is influenced 
by a vast array of mechanisms, some of which are included in Figure 1. Choosing and 
assembling a meaningful subset of these puzzle pieces is an important step in the construction 
of a theoretical GC model. The choice of modules depends on the research question and 
positions the model on a spectrum with high resolution and small scale on one side and 
computational efficiency and larger scale on the other. On the extremes, one may aim to model 
a single GC comprised of diverse cell types at high spatial resolution [33,34] or a large 
ensemble of GCs jointly responding to several consecutive antigen exposures [24,35]. High-
resolution models are important for figuring out the influence of each puzzle piece and thus for 
deciding which mechanisms to carry through to higher level models. They are, however, ill-
suited to predict vaccination success at the organismal level as this builds on several 
sequential rounds of GC reactions, cross-talk between many GCs and the resulting 
amplification of rare high-affinity binders [24].  
 
In general, computational GC models can only be as accurate as the underlying body of 
experimental knowledge. Open questions remain at all scales of GC modelling. For example, 
it is not known how the simultaneous presence of several antigens affects the response to 
individual antigens and whether the response resembles the sum of all parallel responses or 
caps at a defined maximum. Addressing these questions is complicated by differences in 
antigen and epitopes immunogenicity and stability. Furthermore, little is known about how the 
pre-vaccination B cell repertoire of individuals impacts the quality of their GC seeder cells and 
downstream vaccination outcomes. Model accuracy would further benefit from knowing how 
vaccine dosing influences the number of GC seeder cells, the diversity of GC Tfh cells and the 
size and number of resulting GCs. 
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Figure 1 – Modules of germinal centre models. Core modules (dark) are part of most 
simulations. Corresponding optional models (light) can be included depending on the research 
question and scale of interest. AA – amino acid, Ab – antibody, FWR – framework region, CDR 
– complementarity-determining region, ODE – ordinary differential equation, Tfh cell – T 
follicular helper cell, GC – germinal centre. 
 
Understanding clonal evolution in GCs 
 
GC B cell competition for limited resources and concomitant selective expansion rely on the 
fact that GCs are composed of B cells with different antigen affinities. The clonal composition 
changes throughout the GC lifetime as novel B cell clones enter, emerge by somatic mutation, 
expand and contract. Understanding these dynamics and the resulting clonal relationships of 
B cells found in the periphery is of central relevance when designing vaccines as it links to 
optimal epitope mixtures and scheduling.  
 
Historically, it was believed that GCs are seeded by only 3-5 low-affinity founder cells which 
then expand massively while diversifying via somatic hypermutation [36,37]. However, recent 
in vivo visualisations of the murine GC response have revealed that individual GCs are typically 
seeded by 50-200 founder cells and lose diversity at different rates thereafter [38,39]. 
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Nonetheless, many current simulations still build on the assumption that the number of founder 
cells is low. This is problematic as it restricts GC maturation in large to mutation-based affinity 
improvements. By contrast, the contribution of selective expansion of rare high-quality 
precursors to overall improvement can be substantial if a large and diverse pool of GC founder 
cells is considered [24]. Correspondingly, the mean affinity of a GC B cell population correlates 
negatively with its clonal diversity in a setting with many different founder cells [40]. However, 
highly abundant subclones do not necessarily have highest affinity, as best variants can arise 
late during the reaction and thus have insufficient time for expansion [41]. Caution is also 
necessary when interpreting the number of somatic hypermutations as an indicator of affinity 
maturation – the number of mutations an antibody has accumulated and its affinity do not 
necessarily correlate [24,41]. 
 
How clonal dynamics differ in settings with several, potentially differentially immunogenic 
epitopes present at the same time remains to be investigated experimentally. In vivo imaging 
tools like “brainbow GCs” [38] proved useful, but the interpretation of the data requires care – 
based on computer simulations several caveats regarding timing, dynamics and dosage of 
colour induction have been identified [42]. On a related note, GC models have been used to 
identify complications in the construction of B cell lineage trees with the aim of establishing 
mutational paths from germline Ig sequences to higher-affinity descendants. Here, simulations 
show that tree inference on selection-shaped datasets of BCR sequences is significantly more 
complicated than on datasets produced by neutral evolution [43]. 
 
 
Manipulating GC selection processes 
 
Antibodies are correlates of protection in the majority of currently licensed vaccines and have 
been shown to also convey protection against HIV, malaria and influenza [44–46]. However, 
for several reasons including quickly mutating antigens and the parallel display of multiple 
epitopes, these diseases still evade efficient vaccination. GC simulations help to understand 
the challenges and aim to yield suggestions for vaccine compositions. 
 
In this context, a current matter of investigation is how GCs, which are thought to be optimised 
for the selection of high-affinity B cells, are able to select for breadth, that is the ability to bind 
and ideally neutralize antigen variants. This is of particular importance for binding to quickly 
evolving pathogens such as HIV or influenza [46,47]. One possible mechanism conveying 
selection advantages can result from a diverse repertoire of Tfh cells: In contrast to their strain-
specific competitors, broadly binding GC B cells take up several antigen variants with differing 
T cell epitopes and may therefore obtain  help from a larger number of different Tfh cells [48]. 
It follows that vaccine mixtures intending to exploit this effect should ideally contain various 
different T and B cell epitopes. The resulting simultaneous presence of several epitopes may 
be comparable to the late stage of the natural HIV infection in which the viral population has 
strongly diversified. Here, the fixation probability of broadly binding lineages has been reported 
to exceed that of antibodies with higher specificity [49]. The optimal immune cocktail for 
eliciting broadly binding antibodies has been suggested to contain 6-8 antigen variants 
separated by 3-10 mutations [50]. However, others have argued that separating conflicting 
selection forces in time by sequential administration of variant antigens leads to more robust 
emergence of broadly binding antibodies [28,35]. 
 
Despite these computational results, it is unclear whether reliably eliciting broadly neutralizing 
antibodies against HIV by vaccination and thus within a practicable time frame is an attainable 
goal. Broadly neutralizing antibodies against HIV typically display high numbers of 
hypermutations many of which are located in the FWRs of antibodies [51]. The emergence of 
such sequences by the random process of hypermutations is an extremely rare event and 
consequently, on average, takes a long time. While existing computational models in this area 
rely on the assumption that a successful vaccination scheme exists, it would be equally 
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relevant to computationally explore what the waiting time until emergence of broad binders is 
expected to be. 
 
 
Leveraging amplification of the right precursors 
 
It is often assumed that B cell immune responses start from low-affinity precursor cells only 
because pre-exposure serum titres are typically low. However, measuring serum titres is 
measuring a bulk quantity and a low titre does not exclude the existence of small populations 
of high-affinity B cells. As an example, in the case of the malaria parasite Plasmodium 
falciparum, previously unexposed human subjects were found to possess rare high-affinity 
naïve and memory B cells against the parasite surface protein PfCSP [24]. B cell vaccine 
responses relied largely on the clonal selection of these precursors along a triple-immunisation 
protocol. Based on a large-scale simulation comprising many individual GCs, an emerging 
avalanche effect in which a rare high-affinity precursor is first expanded in a single GC and its 
clonal descendants then go on to seed consecutively more GCs in secondary immune 
responses has been proposed as underlying mechanism.  Activating the right precursors can 
increase immune response efficiency not only against malarial PfCSP, but also against HIV 
where it has been suggested to reduce the number of mutations required until the emergence 
of B cells expressing high-affinity broadly binding and neutralizing antibodies [52]. 
 
However, high-quality precursors are unlikely to exist against all antigens or in all patients. 
Here, novel vaccine administration schemes may help drive mutational affinity improvement 
by prolonging GC responses. While many established vaccines are administered 3-4 times at 
intervals of weeks to months with constant dosing [53], a recent mouse study tested various 
non-standard schemes including some with exponentially increasing or decreasing daily 
antigen doses over 1 or 2 weeks and employed mathematical modelling to interpret the results 
[54]. Serum-antibody feedback has been identified as a key factor. Early in the response, 
antigen is lost quickly from the lymph nodes, presumably because it cannot be retained in the 
form of immune complexes on FDCs by low-affinity antibodies. In contrast, antigen that is 
administered after a higher affinity response has developed can be captured and displayed for 
prolonged periods of time, thus allowing a much stronger response to develop. Such strategies 
have shown potential in non-human primate responses against HIV [55]. 
 
In summary, depending on boundary conditions like precursor availability and the mutational 
distance between them and a high-affinity binder, promising building blocks for vaccination 
strategies are emerging. Future simulations of the B cell response should pick up on this and 
aim at optimising protocols on a case-to-case basis. Considering the interplay of various 
germinal centres may prove to be essential for obtaining physiologically relevant results. 
 
 
Conclusions 
 
Computational models of affinity maturation can be employed to explore GC mechanisms as 
well as vaccination strategies. Interesting findings often emerge if such models are 
developed in conjunction with experimental studies, as mathematical models can assist the 
interpretation of experimental data and the development of novel testable hypotheses. Half of 
the studies reviewed here are directly available in online repositories (Table 1). This 
facilitates re-use and adaptation of existing models. In the future, computational models may 
mature to allow prediction of vaccination outcomes based on key parameters such as 
vaccine composition, administration schedule and the pre-vaccination B cell repertoire of 
individual patients.  
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Table 1: Recent Germinal Centre Simulations and Where to Find Them. Plain text versions 
of repository links are provided at the end of the manuscript. 
Topic Motivation Model Feature of interest 
Language, 
Availability, 
Article 
broadly 
binding 
antibodies 
(bbAbs) 
 
Investigate how GCs can 
select for binding breadth 
Uses an antigen model that 
consists of B and T cell epitopes, 
has explicit treatment of Tfh cell 
repertoire 
C, available 
upon request 
[48] 
Facilitate eliciting bbAbs 
against HIV with immunization 
cocktails 
Allows to vary composition of the 
vaccine: number of ingredients, 
mutational distance between 
them, individual concentration 
unknown, no 
availability 
statement [50] 
Facilitate eliciting bbAbs in 
chronic infections like HIV 
Analytical description of antigen-
antibody co-evolution with 
accompanying simulation 
Julia, available 
on github link 
[49] 
Understand evolutionary 
trajectories towards HIV-
bbAbs from different starting 
points 
Binding model with separate 
contributions of binding energies 
and antibody framework region 
flexibility 
Python, 
available on 
github link [52] 
GC 
dynamics & 
B cell 
diversity 
 
Investigate how clonal 
diversity within individual GCs 
evolves over time 
Implements and compares birth- 
and death-limited selection 
mechanisms 
Matlab, 
available on 
github link [40] 
Generate benchmarking data 
for tree inference of antibody 
clones 
Binding model uses nucleotide 
representation and replacements 
happen based on literature-
backed mutabilities 
Python, 
available on 
github link [43] 
  
Provide basis for interpretation 
of multi-colour stained GC 
reactions [38] 
High-resolution 3D lattice 
simulation comprising Tfh cells, 
FDCs, stromal cells, B cells and 
their interactions 
C++ and R, 
available on 
figshare link [42] 
Examine relation between 
clone abundance and affinity 
Combines deterministic clonal 
evolution with stochastic 
emergence of new clones 
R, available 
upon request 
[41] 
molecular 
mechanisms  
 
Understand the role of 
dopamine in Tfh-B cell 
contacts in GCs 
Integrates specific molecular detail 
into existing agent-based model 
C++, available 
upon request 
[33] 
Let GC processes emerge 
from cellular decisions rather 
than predefining event 
sequences 
Links cellular behaviour and 
molecular mechanism via 
concentration-dependent rates 
Matlab and 
Fortran 95, no 
availability 
statement [34] 
vaccine 
schedules  
 
Compare performance of 
sequential and parallel 
administration of HIV variants 
for eliciting breadth 
Introduces binding model with 
conserved and variable parts as 
well as distracting epitopes 
unknown, no 
availability 
statement [35] 
Understand dominance of 
lowly mutated, high-affinity B 
cells after malaria vaccination 
scheme 
Disentangles contributions of 
selection and mutation to affinity 
maturation for simple and complex 
antigens 
Python, 
available on 
github link [24] 
 
Understand antibody 
responses to several non-
standard vaccination schemes 
Incorporates antibody-feedback in 
a simple system of ODEs with 
predefined affinity maturation 
(not applicable, 
small set of 
differential 
equations) [54] 
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